当前位置:首页 - 行情中心 - 星昊医药(920017) - 财务分析 - 现金流量表

星昊医药

(920017)

  

流通市值:22.24亿  总市值:22.48亿
流通股本:1.24亿   总股本:1.25亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金169,972,181.86668,879,414.12504,051,042.5325,780,765.54
  收到的税费返还02,076,270.252,076,270.252,076,270.25
  收到其他与经营活动有关的现金20,793,160.8860,405,434.0834,541,346.3815,985,085.33
  经营活动现金流入小计190,765,342.74731,361,118.45540,668,659.13343,842,121.12
  购买商品、接受劳务支付的现金26,973,251.94116,784,764.12120,148,057.461,103,389.78
  支付给职工以及为职工支付的现金22,409,427.3394,712,549.7872,328,486.2652,144,183.42
  支付的各项税费19,402,213.4363,502,586.3748,672,396.2733,378,971.77
  支付其他与经营活动有关的现金49,620,054.87282,137,211.56215,339,660.64141,097,709.07
  经营活动现金流出小计118,404,947.57557,137,111.83456,488,600.57287,724,254.04
  经营活动产生的现金流量净额72,360,395.17174,224,006.6284,180,058.5656,117,867.08
二、投资活动产生的现金流量:
  收回投资收到的现金335,252,246.49909,000,000732,030,000454,030,000
  取得投资收益收到的现金3,885,579.126,630,042.475,713,573.973,399,410.96
  处置固定资产、无形资产和其他长期资产收回的现金净额-4,0004,000-
  收到的其他与投资活动有关的现金-16,060,190.0516,060,190.0516,060,190.05
  投资活动现金流入小计339,137,825.61931,694,232.52753,807,764.02473,489,601.01
  购建固定资产、无形资产和其他长期资产支付的现金33,867,523.66113,628,725.9140,520,134.3422,281,370.33
  投资支付的现金418,000,000980,000,000755,000,000436,000,000
  支付其他与投资活动有关的现金-11,622,163.44--
  投资活动现金流出小计451,867,523.661,105,250,889.35795,520,134.34458,281,370.33
  投资活动产生的现金流量净额-112,729,698.05-173,556,656.83-41,712,370.3215,208,230.68
三、筹资活动产生的现金流量:
  吸收投资收到的现金-33,118,47033,118,470-
  收到其他与筹资活动有关的现金-6,403,870.78--
  筹资活动现金流入小计039,522,340.7833,118,4700
  分配股利、利润或偿付利息支付的现金58,75019,676,513.819,617,111.0319,557,055.48
  支付其他与筹资活动有关的现金-823,798.8--
  筹资活动现金流出小计58,75020,500,312.619,617,111.0319,557,055.48
  筹资活动产生的现金流量净额-58,75019,022,028.1813,501,358.97-19,557,055.48
四、汇率变动对现金及现金等价物的影响-524,448.8964,379.321,100,650.571,195,239.22
五、现金及现金等价物净增加额-40,952,501.6820,653,757.2957,069,697.7852,964,281.5
  加:期初现金及现金等价物余额446,205,408.12413,929,487.39413,929,487.39413,929,487.39
  期末现金及现金等价物余额405,252,906.44434,583,244.68470,999,185.17466,893,768.89
补充资料:
  净利润-103,044,799.11-41,083,255.36
  资产减值准备-6,368,590.38-3,068,019.01
  固定资产和投资性房地产折旧-47,922,830.77-23,849,129.54
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-47,922,830.77-23,849,129.54
  无形资产摊销-4,244,937.55-2,707,531.75
  长期待摊费用摊销-68,807.34-68,807.34
  处置固定资产、无形资产和其他长期资产的损失-36.47--
  固定资产报废损失-348.31--
  公允价值变动损失--3,538,306.82--2,276,969.84
  财务费用--2,942,555.57--1,210,635.12
  投资损失--3,802,693.03--1,300,088.96
  递延所得税-2,938,468.95-527,169.8
  其中:递延所得税资产减少-2,452,717.52-496,951.62
    递延所得税负债增加-485,751.43-30,218.18
  存货的减少--8,392,295.7--4,349,529.71
  经营性应收项目的减少-5,915,323.94-13,929,068.77
  经营性应付项目的增加-10,457,875.5--20,832,093.09
  现金的期末余额-434,583,244.68-466,893,768.89
  减:现金的期初余额-413,929,487.39-413,929,487.39
  现金及现金等价物的净增加额-20,653,757.29-52,964,281.5
公告日期2026-04-292026-04-242025-10-282025-08-08
审计意见(境内)标准无保留意见
TOP↑